Prolonged duration local anesthesia from tetrodotoxin-enhanced local anesthetic microspheres

Area of Science:

• Pharmacology
• Neuroscience
• Biomaterials

Background:

• Development of local anesthetics with prolonged duration is of significant clinical interest.
• Microsphere technology offers potential for controlled drug release and extended therapeutic effects.
• Tetrodotoxin (TTX) and dexamethasone are investigated for their potential to modulate anesthetic duration and efficacy.

Purpose of the Study:

• To evaluate the efficacy of tetrodotoxin (TTX) in prolonging the nerve block duration of bupivacaine microspheres.
• To assess the combined effects of TTX and dexamethasone with bupivacaine in a controlled-release formulation.
• To investigate the safety profile and histological effects of TTX-containing microspheres.

Main Methods:

• Rat sciatic nerve blocks were administered using microspheres containing bupivacaine, TTX, and/or dexamethasone.
• Nociceptive and motor blockade durations were quantified.
• Histological assessment of nerves and muscles was performed two weeks post-injection.

Main Results:

• Coencapsulation of TTX with bupivacaine and dexamethasone resulted in a median nociceptive block duration of 221.7 hours.
• Bupivacaine alone provided a 6.2-hour block, while combinations with TTX and/or dexamethasone showed extended durations.
• High concentrations of TTX (0.1%) were lethal, and 0.05% TTX caused deficits; localized inflammation and myotoxicity were observed.

Conclusions:

• Coencapsulation of TTX in bupivacaine and dexamethasone microspheres can achieve very prolonged nerve blocks.
• The tested formulation exhibited a narrow safety margin, highlighting the need for careful dose optimization.
• While myotoxicity was observed, its long-term significance requires further investigation.